In Part I of this series, the unique considerations about medicating children at different ages were addressed. In Part II, examples of medications used to treat common short-term illnesses in younger patients were examined. In this part, examples of medications used to treat children with two long-term conditions, asthma and attention-deficit/hyperactivity disorder, are identified. Action, contraindications, and safety concerns for these agents are addressed. The challenges and lifestyle changes that these chronic problems pose for children and their parents are also discussed.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/01.NOR.0000295963.79203.12 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A positive psychotherapy group intervention to increase distress tolerance and reduce feelings of entrapment in patients with multiple sclerosis.
J Educ Health Promot
November 2024
Department of Neurologist, Neurologist Research Center, Faculty of Medical Sciences, Isfahan, Iran.
Background: Multiple sclerosis is a central neurogenic demyelinating disease. This is one of the most common neurological diseases in humans and is the most debilitating at a young age. Symptoms of multiple sclerosis include vision problems, balance problems, dizziness, sensory disturbances, chronic neuropathy, and fatigue.
View Article and Find Full Text PDFPerspectives on the use of decellularized/devitalized and lyophilized human perinatal tissues for bone repair: Advantages and remaining challenges.
Mater Today Bio
February 2025
Université de Franche-Comté, Laboratoire SINERGIES, F-25000 Besançon, France.
Human amniotic membrane (hAM) has been extensively used for several decades as a bioactive scaffold for regenerative medicine. In its cryopreserved form-one of the main storage formats-the presence of viable cells has often been questioned. Furthermore, there is little published evidence of the role of endogenous amniotic cells from cryopreserved hAM in tissue repair.
View Article and Find Full Text PDFMasking in Active Comparator Designs in Pharmacovigilance: A Retrospective Bias Analysis on the Spontaneous Reporting of Thiazolidinediones and Cardiovascular Events.
Pharmacoepidemiol Drug Saf
January 2025
School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.
Introduction: Masking is a reporting bias where drug safety signals are muffled by elevated reporting of other medications in spontaneous reporting databases. While the impact of masking is often limited, its effect when using restricted designs, such as active comparators, can be consequential.
Methods: We used data from the US Food and Drugs Administration Adverse Event Reporting System (1999Q3-2013Q3) to study masking in a real-world example.
Evidence-Based Evaluation of Student and Marker Performances in Assessment and Examination.
Adv Physiol Educ
January 2025
School of Cardiovascular and Metabolic Health, College of Medical, Veterinary and Life Sciences, University of Glasgow.
Students are assessed by coursework and/or exams, all of which are marked by assessors (markers). Student and marker performances are then subject to end-of-session board of examiner handling and analysis. This occurs annually and is the basis for evaluating students, but also the wider learning and teaching efficiency of an academic institution.
View Article and Find Full Text PDFAchieving Language Justice in Pediatric Hematology-Oncology: A Multinational Perspective for Language-Concordant Equitable Patient- and Family-Centered Care and Research Inclusion.
Pediatr Blood Cancer
January 2025
Department of Pediatrics, Division of Pediatric Hematology/Oncology, University of California San Diego/Rady Children's Hospital San Diego, San Diego, California, USA.
Language-discordant healthcare encounters-when the patient/caregiver and clinician are not able to communicate directly in the patient's/caregiver's preferred language-are associated with worse quality of care, increased adverse events, and research exclusion. Here, we describe the current state of language justice in clinical practice and research in the United States, Canada, and Spain, discuss the role of social determinants of health and language, in patient safety and health outcomes and review an example of culturally and linguistically concordant interventions to increase research participation. We close with practical and global strategies to increase multilingual research participation and to provide equitable patient- and family-centered care in pediatric hematology-oncology.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!